FDA’s review of MDMA for PTSD highlights study bias and safety concerns
The comments section on this article is illuminating beyond the story itself (as is frequently the case on Ars) and worth a look....
![](https://supermeter.social/index.php/media/cache/resolve/entry_thumb/d6/8d/d68d60a601cc6b6daa0c180eed71148c7e3daba87c5eab8294a9219b5e0e50ac.jpg)
The comments section on this article is illuminating beyond the story itself (as is frequently the case on Ars) and worth a look....